Virulence Profiles of Bacteremic Extended-Spectrum β-Lactamase-Producing Escherichia coli: Association with Epidemiological and Clinical Features

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  Rodríguez Baño, Jesús ^a,b   Mingorance, Jesús ^c   Fernández Romero, Natalia ^c   Serrano, Lara ^a   López Cerero, Lorena ^a   Pascual, Alvaro ^a,c   Gijón, Paloma ^d   Ramón, José ^a   Cisneros, Jose M ^e   Peña, Carmen ^f  

^a HOSPITAL UNIVERSITARIO VIRGEN MACARENA   (Spain)

^b HOSPITAL UNIVERSITARIO LA PAZ IDIPAZ   (Spain)

^c UNIVERSITY OF SEVILLE   (Spain)

^d HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^e HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^f HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CEFUROXIME; CIPROFLOXACIN; COTRIMOXAZOLE; FOSFOMYCIN; GENTAMICIN; HOST FACTOR; PIPERACILLIN PLUS TAZOBACTAM; TIGECYCLINE; VIRULENCE FACTOR;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; BLOODSTREAM INFECTION; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE PREDISPOSITION; ESCHERICHIA COLI; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ENTEROBACTERIACEAE; FEMALE; GENE; GENE FREQUENCY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; ISOELECTRIC FOCUSING; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; NEUTROPENIA; NONHUMAN; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDY; VIRULENCE FACTOR GENE;

AGED; AGED, 80 AND OVER; ANTI-INFECTIVE AGENTS; BACTEREMIA; BETA-LACTAMASES; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; GENES, BACTERIAL; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MULTIGENE FAMILY; MULTIVARIATE ANALYSIS; PHYLOGENY; SPAIN; VIRULENCE; VIRULENCE FACTORS;

ESCHERICHIA COLI;

EID: 84866077930     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0044238     Document Type: Article

References (36)

1. Picard B, Sevali J, Gouriou S, Duriez P, Brahimi N, et al. (1999) The link between phylogeny and virulence in Escherichia coli extraintestinal infection. Infect Immun 67: 546-553.
2. Johnson JR, Stell AL, (2000) Extended virulence genotypes of Escherichia coli strains from patients with urosepsis in relation to phylogeny and host compromise. J Infect Dis 181: 261-272.
3. Sannes MR, Kuskowski MA, Owens K, Gajewski A, Johnson JR, (2004) Virulence factor profiles and phylogenetic background of Escherichia coli isolates from veterans with bacteremia and uninfected control subjects. J Infect Dis 190: 2121-2128.
4. Moreno E, Planells I, Prats G, Planes AM, Moreno G, Andreu A, (2005) Comparative study of Escherichia coli virulence determinants in strains causing bacteremia versus strains causing pyelonephritis and other sources of bacteremia. Diag Microbiol Infect Dis 53: 93-99.
5. Bukh AS, Schønheyder HC, Emmersen JM, Søgaard M, Bastholm S, et al. (2009) Escherichia coli phylogenetic groups are associated with site of infection and level of antibiotic resistance in community-acquired bacteraemia: a 10 year population-based study in Denmark. J Antimicrob Chemother 64: 163-168.
6. Cooke NM, Smith SG, Kelleher M, Rogers TR, (2010) Major differences in frequencies of virulence factors and multidrug resistance between community and nosocomial Escherichia coli bloodstream isolates. J Clin Microbiol 48: 1099-1104.
7. Lefort A, Panhard X, Clermont O, Woerther P-L, Branger C, et al. (2011) Host factors and portal of entry outweight bacterial determinants to predict the severity of Escherichia coli bacteremia. J Clin Microbiol 49: 777-783.
8. Courpon-Claudinon A, Lefort A, Pahnard X, Clermond O, Dornic Q, et al. (2011) Bacteraemia caused by third-generation cephalosporin-resistant Escherichia coli in France: prevalence molecular epidemiology, and clinical features. Clin Microbiol Infect 17: 557-565.
9. Johnson JR, Kuskowski MA, O'Bryan TO, Maslow JN, (2002) Epidemiological correlates of virulence genotype and phylogenetic background among Escherichia coli blood isolates from adults with diverse-source bacteremia. J Infect Dis 185: 1439-1447.
10. Moreno E, Prats G, Planells I, Planes AM, Pérez T, et al. (2006) Characterization of Escherichia coli isolates derived from phylogenetic groups A and B1 causing extraintestinal infection. Enferm Infecc Microbiol Clin 24: 483-489.
11. Johnson JR, Russo TA, (2005) Molecular epidemiology of extraintestnal pathogenic (uropathogenic) Escherichia coli. Int J Med Microbiol 295: 383-404.
12. Wang MC, Tseng CC, Chen CY, Wu JJ, Huang JJ, (2002) The role of bacterial virulence and host factors in patients with Escherichia coli bacteremia who have acute cholangitis or upper urinary tract infection. Clin Infect Dis 35: 1161-1166.
13. Rodríguez-Baño J, Picón E, Gijón P, Hernández JR, Ruíz M, et al. (2010) Community-onset bacteremia due to extended-spectrum beta-lactamase-producing Escherichia coli: risk factors and prognosis. Clin Infect Dis 50: 40-48.
14. Rodríguez-Baño J, Picón E, Gijón P, Hernández JR, Cisneros JM, et al. (2010) Risk factors and prognosis of nosocomial bloodstream infections caused by extended-spectrum β-lactamase-producing Escherichia coli. J Clin Microbiol 48: 1726-1731.
15. van der Bij AK, Peirano G, Goessens WH, van der Vorm ER, van Westreenen M, et al. (2011) Clinical and molecular characteristics of extended-spectrum-beta-lactamase-producing Escherichia coli causing bacteremia in the Rotterdam Area, Netherlands. Antimicrob Agents Chemother 55: 3576-3578.
16. Lavigne JP, Blanc-Potard AB, Bourg G, Moreau J, Chanal C, et al. (2006) Virulence genotype and nematode-killing properties of extra-intestinal Escherichia coli producing CTX-M beta-lactamases. Clin Microbiol Infect 12: 1199-1206.
17. Clermont O, Lavollay M, Vimont S, Deschamps C, Forestier C, et al. (2008) The CTX-M-15-producing Escherichia coli diffusing clone belongs to a highly virulent B2 phylogenetic subgroup. J Antimicrob Chemother 61: 1024-1028.
18. Lavigne JP, Vergunst AC, Goret L, Sotto A, Combescure C, et al. (2012) Virulence potential and genomic mapping of the worldwide clone Escherichia coli ST131. PLoS One 7: e34294.
19. Charlson ME, Pompei P, Ales KL, MacKenzie CR, (1987) A new method of classifying prognostic co-morbidity in longitudinal studies: development and validation. J Chron Dis 40: 373-383.
20. Clinical and Laboratory Standard Institute (CLSI) (2009) Performance Standards for Antimicrobial Susceptibility Testing; 19th Informational Supplement. CLSI document M100-S19. CLSI, Wayne, PA, USA.
21. Clermont O, Dhanji H, Upton M, Gibreel T, Fox A, et al. (2009) Rapid detection of the O25b-ST131 clone of Escherichia coli encompassing the CTX-M-15-producing strains. J Antimicrob Chemother 64: 274-277.
22. Clermont O, Bonacorsi S, Bingen E, (2000) Rapid and simple determination of the Escherichia coli phylogenetic group. Appl Environ Microbiol 66: 4555-4558.
23. Le Bouguenec C, Archambaud M, Labigne A, (1992) Rapid and specific detection of the pap, afa, and sfa adhesin-encoding operons in uropathogenic Escherichia coli strains by polymerase chain reaction. J Clin Microbiol 30: 1189-1193.
24. Karkkainen UM, Kauppinen J, Ikaheimo R, Katila ML, Siitonen A, (1998) Rapid and specific detection of three different G adhesin classes of P-fimbriae in uropathogenic Escherichia coli by polymerase chain reaction. J Microbiol Methods 34: 23-29.
25. Blanco M, Blanco JE, Alonso MP, Mora A, Balsalobre C, et al. (1997) Detection of pap, sfa and afa adhesin-encoding operons in uropathogenic Escherichia coli strains: relationship with expression of adhesins and production of toxins. Res Microbiol 148: 745-755.
26. Yamamoto S, Teai A, Yuri K, Kurazono H, Takeda Y, et al. (1995) Detection of urovirulence factors in Escherichia coli by multiplex polymerase chain reaction. FEMS Immunol Med Microbiol 12: 85-90.
27. Ananias M, Yano T, (2008) Serogroups and virulence genotypes of Escherichia coli isolated from patients with sepsis. Braz J Med Biol Res 41: 877-883.
28. Nakano M, Yamamoto S, Terai A, Ogawa O, Makino SI, et al. (2001) Structural and sequence diversity of the pathogenicity island of uropathogenic Escherichia coli which encodes the USP protein. FEMS Microbiol Lett 205: 71-76.
29. Russo TA, Carlino UB, Johnson JR, (2001) Identification of a new iron-regulated virulence gene, ireA, in an extraintestinal pathogenic isolate of Escherichia coli. Infect Immun 69: 6209-6216.
30. Girardeau JP, Lalioui L, Said AM, De Champs C, Le Bouqiénec C, (2003) Extended virulence genotype of pathogenic Escherichia coliiIsolates carrying the afa-8 operon: evidence of similarities between isolates from humans and animals with extraintestinal infections. J Clin Microbiol 41: 218-226.
31. Bidet P, Metais A, Mahjoub-Messai F, Durand L, Dehem M, et al. (2007) Detection and identification by PCR of a highly virulent phylogenetic subgroup among extraintestinal pathogenic Escherichia coli B2 strains. Appl Environ Microbiol 72: 2373-2377.
32. Nicolas-Chanoine MH, Blanco J, Leflon-Guibout V, Demarty R, Alonso MP, et al. (2008) Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15. J Antimicrob Chemother 61: 271-281.
33. Pitout JDD, Gregson DG, Campbell L, Laupland KB, (2009) Molecular characteristics of extended-spectrum-β-lactamase-producing Escherichia coli isolates causing bacteremia in the Calgary Health Region from 2000 to 2007: emergence of clone ST131 as a cause of community-acquired infections. Antimicrob Agents Chemother 53: 2846-2851.
34. Brisse S, Diancourt L, Laouénan C, Vigan M, Caro V, et al. (2012) Phylogenetic distribution of CTX-M and non-ESBL producing Escherichia coli isolates: group B2 isolates, except clone ST131, rarely produce CTX-M enzymes. J Clin Microbiol (in press).
35. Bert F, Johnson JR, Ouattara B, Leflon-Guibout V, Johnston B, et al. (2010) Genetic diversity and virulence profiles of Escherichia coli isolates causing spontaneous bacterial peritonitis and bacteremia in patients with cirrhosis. J Clin Microbiol 48: 2709-2714.
36. Johnson JR, O'Bryan TT, Kuskowski M, Maslow JN, (2001) Ongoing horizontal and vertical transmission of virulence genes and papA alleles among Escherichia coli blood isolates from patients with diverse source bacteremia. Infect Immun 9: 5363-5374.